The prognostic value of lymph node ratio in survival of head-and-neck squamous cell carcinoma

Reza Eshraghi Samani, Mohammad Shirkhoda, Maryam Hadji, Faramarz Beheshtifard, Seyed Mohammad Mehdi Ghaffari Hamedani, Ali Momen, Mahtab Mollashahi, Kazem Zendehdel, Reza Eshraghi Samani, Mohammad Shirkhoda, Maryam Hadji, Faramarz Beheshtifard, Seyed Mohammad Mehdi Ghaffari Hamedani, Ali Momen, Mahtab Mollashahi, Kazem Zendehdel

Abstract

Background: Head-and-neck squamous cell carcinoma (HNSCC) is the sixth most prevalent type of cancers in the world. Due to its relatively high rate of recurrence, the prognosis of patients is poor and the survival rate is low; therefore, identifying the prognostic factors is considered necessary for better treatment.

Materials and methods: This historical cohort study was conducted on 201 patients diagnosed with aerodigestive SCC who underwent surgery and lymph node dissection. We determined the prognostic value of lymph node ratio (LNR) on overall survival (OS), disease-free survival (DFS), and locoregional failure-free survival (LFFS). We noticed an association between LNR and survival by Kaplan-Meier analysis. Hazard ratio (HR) of LNR was determined by Cox's regression model.

Results: Two hundred and one patients entered this study after their medical histories were evaluated. The mean of lymph node count and LNR was 14.30 (±9.50) and 0.12 (±0.23), respectively. Eighty patients (39.80%) experienced recurrence of SCC. Five-year OS, DFS, and LFFS were 32%, 21%, and 64%, respectively. The median of OS was 40.70 months and 30.11 months in patients with LNR of ≤0.06 and >0.06, respectively (P < 0.01). The LNR >0.06 was found to be a significant prognostic factor for lower OS of patients with HNSCC (HR = 2.11 [1.10, 4.40]; P = 0.04). DFS was not significantly different among patients with LNR ≤0.06 and patients with LNR >0.06 (P = 0.9). However, LFFS was slightly different among two groups (HR = 2.04 [0.90-4.80]; P < 0.1).

Conclusion: We recommend more intensive adjuvant therapies such as chemotherapy with radiotherapy and short interval follow-up for patients with LNR >0.06. Further investigations with larger sample sizes are recommended.

Keywords: Head-and-neck squamous cell carcinoma; lymph node ratio; survival.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Overall survival estimates based on lymph node ratio
Figure 2
Figure 2
Overall survival estimates based on stage

References

    1. American Cancer Society. Cancer facts and figures 2017. Genes Dev. 2017;21:2525–38.
    1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology. 2017;3:524–48.
    1. Pai SI, Westra WH. Molecular pathology of head and neck cancer: Implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49–70.
    1. Marur S, Forastiere AA. Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91:386–96.
    1. Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012;13:35–46.
    1. Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, et al. Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 2014;6:44.
    1. Feng Z, Xu QS, Wang C, Li JZ, Mao MH, Li H, et al. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer. Sci Rep. 2017;7:6708.
    1. Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.
    1. Gődény M. Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM. Cancer Imaging. 2014;14:15.
    1. Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, et al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol. 2012;48:329–36.
    1. Chen CC, Lin JC, Chen KW. Lymph node ratio as a prognostic factor in head and neck cancer patients. Radiat Oncol. 2015;10:181.
    1. Herr HW. The concept of lymph node density – Is it ready for clinical practice? J Urol. 2007;177:1273–5.
    1. Ooki A, Yamashita K, Kobayashi N, Katada N, Sakuramoto S, Kikuchi S, et al. Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma. World J Surg. 2007;31:2184–91.
    1. Calcagno C, Lobatto ME, Robson PM, Millon A. HHS public access. Diagn Microbiol Infect Dis. 2016;28:1304–14.
    1. Polterauer S, Hefler L, Seebacher V, Rahhal J, Tempfer C, Horvat R, et al. The impact of lymph node density on survival of cervical cancer patients. Br J Cancer. 2010;103:613–6.
    1. Jacobi C, Rauch J, Hagemann J, Lautz T, Reiter M, Baumeister P. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status. Eur Arch Otorhinolaryngol. 2017:1–0.
    1. Wang B, Zhang S, Yue K, Wang XD. The recurrence and survival of oral squamous cell carcinoma: A report of 275 cases. Chin J Cancer. 2013;32:614–8.
    1. Cadoni G, Giraldi L, Petrelli L, Pandolfini M, Giuliani M, Paludetti G, et al. Prognostic factors in head and neck cancer: A 10-year retrospective analysis in a single-institution in Italy. Acta Otorhinolaryngol Ital. 2017;37:458–66.
    1. Axelsson L, Nyman J, Haugen-Cange H, Bove M, Johansson L, De Lara S, et al. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection. J Otolaryngol Head Neck Surg. 2017;46:45.
    1. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J, et al. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994;168:494–8.
    1. Roberts TJ, Colevas AD, Hara W, Holsinger FC, Oakley-Girvan I, Divi V, et al. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer. 2016;122:1388–97.
    1. Chow TL, Kwan WW, Fung SC, Ho LI. Prognostic value of lymph node density in buccal squamous cell carcinoma. Am J Otolaryngol. 2017;38:529–32.
    1. Wang YL, Feng SH, Zhu J, Zhu GP, Li DS, Wang Y, et al. Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: A population-based analysis. PLoS One. 2013;8:e56613.
    1. Sayed SI, Sharma S, Rane P, Vaishampayan S, Talole S, Chaturvedi P, et al. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients? J Surg Oncol. 2013;108:256–63.
    1. Xing Y, Zhang J, Lin H, Gold KA, Sturgis EM, Garden AS, et al. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer. 2016;122:534–45.
    1. Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M, et al. Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy. Gastric Cancer. 2014;17:67–75.
    1. Xiao XS, Tang HL, Xie XH, Li LS, Kong YN, Wu MQ, et al. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer – Results for 804 Chinese patients from a single institution. Asian Pac J Cancer Prev. 2013;14:5219–23.
    1. Amri R, Klos CL, Bordeianou L, Berger DL. The prognostic value of lymph node ratio in colon cancer is independent of resection length. Am J Surg. 2016;212:251–7.
    1. Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700–10.
    1. Reinisch S, Kruse A, Bredell M, Lübbers HT, Gander T, Lanzer M, et al. Is lymph-node ratio a superior predictor than lymph node status for recurrence-free and overall survival in patients with head and neck squamous cell carcinoma? Ann Surg Oncol. 2014;21:1912–8.
    1. Lanzer M, Kruse A, Lubbers HT, Zemann W, Reinisch S. Lymph node ratio and capsule penetration as independent risk factors in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4:1–8.
    1. de Ridder M, Marres CC, Smeele LE, van den Brekel MW, Hauptmann M, Balm AJ, et al. A critical evaluation of lymph node ratio in head and neck cancer. Virchows Arch. 2016;469:635–41.
    1. Yong-Hong HQ, Yong-Feng P, Qiu Tang ZF. Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. Head Neck. 2014;36:1391.
    1. Shrime MG, Bachar G, Lea J, Volling C, Ma C, Gullane PJ, et al. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1482–8.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir